BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 29
• 30

• BioCapital

  J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology

  December 8, 2008

   · 

  6 min read
• Drug Development

  Sunesis Pharmaceuticals, Inc. Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology

  December 8, 2008

   · 

  8 min read
• Drug Development

  Presentation on Cytopia Limited’s JAK2 Inhibitor Program in Myeloproliferative Disorders

  December 8, 2008

   · 

  1 min read
• Biotech Beach

  eBioscience, Inc. Announces an Expansion of the eFluor(TM) Brand with the Commercial Launch of eFluor(TM) Organic Dyes

  December 8, 2008

   · 

  2 min read
• Drug Development

  Millennium: The Takeda Oncology Company Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients

  December 8, 2008

   · 

  9 min read
• Drug Development

  Rib-X Pharmaceuticals, Inc. Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin

  December 8, 2008

   · 

  5 min read
• Business

  BioWa Licenses POTELLIGENT(R) Technology to GlaxoSmithKline for Use in Antibody Development and Commercialization

  December 8, 2008

   · 

  2 min read
• Drug Development

  Halozyme Therapeutics, Inc. Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target

  December 8, 2008

   · 

  4 min read
• Pharm Country

  Eli Lilly and Company And Bristol-Myers Squibb Company Release: ERBITUX(R) Supplemental Biologics License Application for Advanced Non-Small Cell Lung Cancer Submitted to U.S. FDA

  December 8, 2008

   · 

  1 min read
• Drug Development

  GlycoMimetics, Inc. to Present New Results of Lead Candidate in Additional Animal Models of Sickle Cell Disease at American Society of Hematology Annual Meeting

  December 8, 2008

   · 

  1 min read